71
Growth Score in past quarter
pts
Heat Score 71 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1223507
CanFel Therapeutics is an emerging veterinary oncology company
About the Company
CanFel's founding team has extensive experience discovering and developing antibody drugs for use in humans and is applying this expertise to develop new antibody drugs for companion animals. Leveraging CanFel's innovative, "biology-driven" cCSC development platform, that utilizes advanced cell-based discovery techniques, they
are developing canine and feline versions of antibody therapeutics widely used to treat cancer in humans.